Company / Capital Expenditures
Illumina, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$148.0M
FY2025
5-year range
$128.0M / $208.0M
FY2021-FY2025
Trend
+15.6%
vs FY2024
Sector context
#48 of 151
Health Care
What the data says
At $148M, Illumina, Inc.'s capital expenditures ranks #48 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $128M in FY2024 to $310M in FY2019.
Based on SEC 10-K filings.
$148M in FY2025 with a 5-year CAGR of -4.8%.
Declined from $195M to $148M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- -4.8%
- 10-Year CAGR
- -
Sector benchmark
#48 of 151 in Health CareTop 32% of 151This company $148.0M Sector average $271.7M
▼
-45.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.8%, indicating a declining trend.
- In FY2025, capital expenditures increased 15.6% year-over-year.
- Ranks #48 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $148.0M | +15.6% |
| FY2024 | $128.0M | -34.4% |
| FY2023 | $195.0M | +3.2% |
| FY2022 | $189.0M | -9.1% |
| FY2021 | $208.0M | +10.1% |
| FY2020 | $189.0M | -39.0% |
| FY2019 | $310.0M | +19.2% |
| FY2018 | $260.0M | +81.8% |
| FY2017 | $143.0M | -45.0% |
| FY2016 | $260.0M | +81.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026